Lisata Therapeutics, Inc. (LSTA)
USD 2.58
(-3.01%)
USD 2.58
(-3.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 121.37 Million | - | - | - | - |
| Cost of Revenue | 189 Thousand | 57.6 Million | 55 Thousand | 63 Thousand | 65 Thousand | 225 Thousand |
| Gross Profit | -189 Thousand | 63.77 Million | -55 Thousand | -63 Thousand | -65 Thousand | -225 Thousand |
| Operating Expenses | 25.7 Million | 57.6 Million | 29.05 Million | 19.14 Million | 20.09 Million | 16.98 Million |
| Selling, General and Administrative Expenses | 12.97 Million | 14.14 Million | 11.37 Million | 9.89 Million | 9.29 Million | 9.39 Million |
| Research and Development Expenses | 12.73 Million | 43.46 Million | 17.68 Million | 9.25 Million | 10.79 Million | 7.59 Million |
| Other Expenses | - | -155 Thousand | -75 Thousand | 132 Thousand | 740 Thousand | 824 Thousand |
| Cost and Expenses | 25.7 Million | 57.6 Million | 29.05 Million | 19.14 Million | 20.09 Million | 16.98 Million |
| Operating Income | -25.7 Million | -57.6 Million | -29.05 Million | -19.14 Million | -20.09 Million | -16.98 Million |
| Interest Expense | - | - | - | - | - | 5000.00 |
| Income Tax Expense | -2.33 Million | -2.47 Million | -1.5 Million | -10.87 Million | 749 Thousand | -1000.00 |
| Earnings before Tax | -23.17 Million | -56.7 Million | -28.97 Million | -19.01 Million | -19.35 Million | -16.16 Million |
| Net Income | -20.84 Million | -54.22 Million | -27.46 Million | -8.14 Million | -20.1 Million | -16.16 Million |
| Earnings Per Share Basic | -2.58 | -10.47 | -7.45 | -7.91 | -29.20 | -25.03 |
| Earnings Per Share Diluted | -2.58 | -10.47 | -7.45 | -7.91 | -29.20 | -25.03 |
| Weighted Average Shares Outstanding | 8.07 Million | 5.18 Million | 3.68 Million | 1.02 Million | 688.33 Thousand | 645.93 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 8.07 Million | 5.18 Million | 3.68 Million | 1.02 Million | 688.33 Thousand | 645.93 Thousand |
| Gross Margin | - | 0.53 | - | - | - | - |
| EBIT Margin | - | -0.48 | - | - | - | - |
| Profit Margin | - | -0.45 | - | - | - | - |
| EBITDA | -25.51 Million | -115.2 Million | -28.99 Million | -19.08 Million | -20.02 Million | -16.76 Million |
| Earnings Before Tax Margin | - | -0.47 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 45 Thousand | 46 Thousand | 47 Thousand | 189 Thousand | 47 Thousand | 48 Thousand |
| Gross Profit | -45 Thousand | -46 Thousand | -47 Thousand | -189 Thousand | -47 Thousand | -48 Thousand |
| Operating Expenses | 5.47 Million | 6.55 Million | 5.97 Million | 25.51 Million | 5.96 Million | 6.87 Million |
| Selling, General and Administrative Expenses | 2.87 Million | 3.31 Million | 2.96 Million | - | 2.58 Million | 3.71 Million |
| Research and Development Expenses | 2.6 Million | 3.24 Million | 3.01 Million | - | 3.38 Million | 3.16 Million |
| Other Expenses | -14 Thousand | -187 Thousand | -11 Thousand | - | -11 Thousand | -150 Thousand |
| Cost and Expenses | 5.52 Million | 6.6 Million | 6.02 Million | 25.7 Million | 5.96 Million | 6.87 Million |
| Operating Income | -5.52 Million | -6.6 Million | -6.02 Million | -25.7 Million | -5.96 Million | -6.87 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -798 Thousand | 3188.00 | -2.33 Million | -714 Thousand | -2.33 Million |
| Earnings before Tax | -5.04 Million | -6.19 Million | -5.36 Million | -23.17 Million | -5.26 Million | -6.35 Million |
| Net Income | -5.04 Million | -5.4 Million | -5.36 Million | -20.84 Million | -5.26 Million | -4.02 Million |
| Earnings Per Share Basic | -0.61 | -0.65 | -0.66 | - | -0.65 | -0.50 |
| Earnings Per Share Diluted | -0.61 | -0.65 | -0.66 | - | -0.65 | -0.50 |
| Weighted Average Shares Outstanding | 8.3 Million | 8.29 Million | 8.14 Million | 8.07 Million | 8.14 Million | 8.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.3 Million | 8.29 Million | 8.14 Million | 8.07 Million | 8.14 Million | 8.02 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -5.47 Million | -6.55 Million | -5.97 Million | - | -6.63 Million | -7.49 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
RALLIS
PL8
AZY
5695
BAJAJELEC
6565